公开(公告)号：EP2146739A2

公开(公告)日：2010-01-27

申请号：EP08766954.5

申请日：2008-05-14

申请人： Fonterra Co-Operative Group Limited

发明人： KANWAR, Jagat, Rakesh ,  KRISSANSEN, Geoffrey, Wayne ,  SUN, Xueying ,  PALMANO, Kay, Patricia ,  MACGIBBON, Alastair, Kenneth, Hugh

IPC分类号： A61K38/40 ,  A23C13/12 ,  A23C15/00 ,  A23C17/00 ,  A23C21/00 ,  A61K31/592 ,  A61K31/593 ,  A61K36/48 ,  A61P25/00 ,  A61P37/00

CPC分类号： A61K36/48 ,  A23C13/12 ,  A23C15/12 ,  A23C17/00 ,  A23C2240/05 ,  A23V2002/00 ,  A61K31/592 ,  A61K31/593 ,  A61K35/20 ,  A61K38/40 ,  A61K2300/00 ,  A23V2250/194 ,  A23V2200/308

摘要： The present invention relates to administration of milk fat or a milk fat analogue, optionally with at least one additional therapeutic factor, preferably lactoferrin or metal ion lactoferrin, preferably iron lactoferrin, preferably bovine lactoferrin, preferably iron bovine lactoferrin, or a metal ion functional variant or functional fragment thereof, to inhibit tumour formation or growth, maintain or improve one or more of the white blood cell count, the red blood cell count, or the myeloid cell count, reduce cachexia, mucositis, and anemia, stimulate the immune system and treat or prevent cancer and the symptoms of cancer and side-effects of cancer therapies. The methods and medicinal uses of the invention may be carried out by employing dietary (as foods or food supplements), nutraceutical or pharmaceutical compositions. Compositions useful in the methods of the invention are also provided.